**Pictures are magnified for illustration and are of one product and you will receive only one vial. Pictures are representative of the final product which may have variations in the cap color.
Studies carried out with SR 9009 have shown that it will decrease:
- Total cholesterol by 47%
- Plasma insulin level by 35%
- Plasma non-esterified fatty acids by 23%
- Plasma glucose by 19%
- Plasma triglycerides by 12%
SR9009 will also decrease proinflammatory cytokine IL-6 by 72%, which is clearly beneficial for reducing inflammation.
SR9009 binds to a protein called Rev-erbA. This is significant since this protein influences fat and sugar burning in the liver, production of fat cells, and the body’s inflammatory responses.
SR9009 does not act like a fat burner, thyroid accelerator, or appetite suppressant. SR 9009 can affect the circadian rhythms, lipid and glucose metabolism, fat-storing cells, as well as macrophages. Due to increases in number of macrophages, defective mitochondria are removed from the muscles and replaced with new ones.
*This description is meant for informational purposes only and is publicly available.